A major study investigating the effectiveness of liver perfusion as a technique to improve the function of donor livers that would have otherwise been rejected has shown that up to 7 in every 10 could be used.
A new partnership between scientists at the University of Birmingham and global healthcare company Novo Nordisk aims to discover new treatments for people suffering from fatty liver disease.
A procedure assessed by NICE and used in research led by the University of Birmingham has been hailed as an "exciting development" in increasing the number of livers which can be safely used for transplantation.
University of Birmingham clinician scientist and hepatologist Dr Ye Htun Oo has been awarded £1.7 million to fund translational biomedical research into autoimmune liver diseases.
The city of Birmingham has also been awarded with Transplant Sport's first ever Donor City Award, in association with the Daily Mirror.